CAS NO.:431579-34-9
MF: C152H252N44O42
MW: 3367.2
Purity: 99.00%
Appearance: White Powder
Grade: Pharmaceutical Grade
YK-11 offers the extreme muscle building properties of steroids without the nasty steroid side effects and is a fantastic solution for those who don't like to use steroids.
Dosage:
Recommended maximum dose YK11 is require dosages of 2.0-5.0mg b.i.d. in males and 0.5mg-2mg b.i.d. in females to achieve optimal effects in humans for the noted indications.
1. Muscle Strength:
It does not come short but really generous of muscle strengthening advantages for users, while the research compound is are new discovery. Muscle tissues subjected to it generates more anabolic results than these uncovered with DHT as suggested within the statement of Kanno.
On that note, it can be safe to say it is best for muscle strengthening, with no detrimental effects caused by steroids that are conventional, including many health hazards. What happens is the fact that it causes muscle tissues, stirring them to produce a higher quantity of follistatin, considerably better than DHT.
Also, it cannot be dismissed this research chemical androgen receptors but doesn't harm the bones and joints and other body parts where ARs are found because of its particular action/activity.
2. Myostat Ininhibitor:
While YK-11 has been proven to work as a great supplement for building muscle strength, especially ideal for bodybuilders and athletes, it is also found to be a great myostatin inhibitor. It is special and valuableas a SARM that acts as a strong androgen but without the side effects you will commonly experience from injectable alternatives, like steroids and prohormones.
It also works as a myostatin inhibitor. What is myostatin, anyway? This is a type of protein that limits the production and the growth of the muscle tissues, when it is present. So by inhibiting myostatin action, you can actually improve your body's potential to build bigger and leaner muscle tissue. But while it sounds too good to be true, it has been proven by the scientists themselves.
What happens is that it also inhibits the production and gradually deactivates follistatin, a myostatin inhibitor. On that note, it can be told that it is a potent and effective myostatin inhibitor aside from its anabolic properties, which means more muscle for you!
3. Muscle Development:
If you're appearing to experience bodybuilding results that are exceptional, you might want to contemplate this research compound, which may be taken at doses between 5 and 8 milligrams daily at an eight-week cycle. Nevertheless, you may be worried about estrogen effects but that from the image.
Additionally, this the expression of other genes will not alter in the body because it leaves out the androgen receptors including joints, the bones and prostate. Thus, you can experience great muscle mass building benefits, except the side effects you might have to face if you'll select steroids that are typical available on the market.
The best part is that it provides all the above mentioned advantages without hurting your body, particularly your liver something which you might need to cope with by selecting other prohormones before any remarkable effects can be attained in the marketplace that might necessitate longer use.
Conclusive details about the compound are not yet been printed and since studies continue to be underway, side effects cannot be noticed at this moment. Based on first and logs findings, there are not any adverse effects noticed at all.
Ostarine,MK-2866, Enobosarm | Enobosarm (Ostarine, MK-2866, GTx-024) - affects both muscle and bone, intended mainly for osteoporosis but also general treatment for andropause and reversing muscle sarcopenia in the elderly and for cachexia in cancer patients. |
LGD-4033 | pharmacological profile similar to that of enobosarm, Ostarine,MK-2866 |
MK-677, Ibutamoren, a hormone secretagogue | a owth hormone secretagogue, treatment of obesity, a promising therapy for the treatment of frailty in the elderly. |
Andarine (S-4) | partial agonist, intended mainly for treatment of benign prostatic hypertrophy. |
GW-501516 | It had been investigated as a potential treatment for obesity, diabetes, dyslipidemia and cardiovascular disease. |
RAD140 | to help reduce the androgenic side effects that can be potentially caused by the same on the prostate. |
SR9009 | to increased metabolic activity in skeletal muscle in both culture and in mice. |